Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-45887  Staphylococcus aureus, HIP09737
(Bacteria)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Staphylococcus aureus
Designations: HIP09737
Biosafety Level: 2
Availability Status: In Stock
Store at: -60°C or colder
Contributor: NARSA
Comments:

Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.


Staphylococcus aureus (S. aureus), strain HIP09737 (also referred to as NRS52) was isolated in 2000 in California, USA, from bile of a female patient who had a history of acute cholecystitis, complicated cholecystectomy and long-term vancomycin treatment for a methicillin-resistant S. aureus (MRSA) infection.

S. aureus, strain HIP09737 is a vancomycin-intermediate S. aureus (VISA) strain. S. aureus, strain HIP09737 was deposited as negative for mecA, vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 5; eGenomic spa type 24, eGenomic spa repeats TJMEMDMGMK; Ridom spa type t242. Strain HIP09737 is reported to be sensitive to quinupristin/dalfopristin, oxacillin, gentamicin, tetracycline and trimethoprim/sulfamethoxazole; intermediate resistant to vancomycin and chloramphenicol; and resistant to erythromycin, clindamycin, levofloxacin, ciprofloxacin and rifampin. Two VISA strains were isolated from this patient, strain HIP09740 (NRS51) and strain HIP09737, which have identical antibiotic susceptibility profiles except for oxacillin and have closely related pulsed-field gel electrophoresis (PFGE) types.


Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.

Note: If homogeneity is required for your intended use, please purify prior to initiating work.

Citations: Acknowledgment for publications should read “The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain HIP09737, NR-45887.”
Additional Information: NARSA NRS52
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search